(Q53326518)

13 May 2018

title

Moderate and advanced Alzheimer's patients exhibit platelet activation differences. (English)

1 reference

13 May 2018

author name string

Davies TA

1

1 reference

13 May 2018

Long HJ

2

1 reference

13 May 2018

Tibbles HE

3

1 reference

13 May 2018

Sgro KR

4

1 reference

13 May 2018

Wells JM

5

1 reference

13 May 2018

Rathbun WH

6

1 reference

13 May 2018

Seetoo KF

7

1 reference

13 May 2018

McMenamin ME

8

1 reference

13 May 2018

Smith SJ

9

1 reference

13 May 2018

Feldman RG

10

1 reference

13 May 2018

Levesque CA

11

1 reference

13 May 2018

Fine RE

12

1 reference

13 May 2018

Simons ER

13

1 reference

13 May 2018

publication date

1 March 1997

1 reference

13 May 2018

published in

Neurobiology of Aging

1 reference

13 May 2018

volume

18

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

155-162

1 reference

13 May 2018

A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

An abnormality of plasma amyloid protein precursor in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Stimulated platelets release amyloid beta-protein precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Flow cytometric measurements of cytoplasmic calcium changes in human platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Activated Alzheimer disease platelets retain more beta amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Low cerebrospinal-fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Characterization of a novel processing pathway for Alzheimer's amyloid beta precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Platelet and erythrocyte membrane changes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Differential energy requirements for platelet responses. A simultaneous study of aggregation, three secretory processes, arachidonate liberation, phosphatidylinositol breakdown and phosphatidate production

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Proteolytic processing of amyloid beta protein precursor (APP) by thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease: a test in population-based cases and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Proteolytic processing of Alzheimer's disease beta A4 amyloid precursor protein in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Platelet protein kinase C levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Cytochrome oxidase deficiency in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Intracellular membranes are more fluid in platelets of Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Detection of soluble forms of the beta-amyloid precursor protein in human plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Quantitative changes in the amyloid βA4 precursor protein in Alzheimer cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Detection of distinct isoform patterns of the beta-amyloid precursor protein in human platelets and lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Factor IXa inhibition by protease nexin-2/amyloid beta-protein precursor on phospholipid vesicles and cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Alzheimer's disease: a central role for amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Amyloid beta protein precursors with kunitz-type inhibitor domains and acetylcholinesterase in cerebrospinal fluid from patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

Platelet membrane abnormality in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2897%2900016-X

7 January 2021

10.1016/S0197-4580(97)00016-X

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018